Beta-blocker Adjunct Therapy As a Prospective Anti-metastatic with Cardio-oncologic Regulation

Overview

Journal Clin Exp Metastasis

Specialty Oncology

Date 2024 Jan 4

PMID 38177715

Authors

Sachin G Nair

Sonu Benny

Wesley M Jose

Aneesh T P

Affiliations

Soon will be listed here.

Abstract

The prevailing treatment stratagem in cancer therapy still challenges the dilemma of a probable metastatic spread following an initial diagnosis. Including an anti-metastatic agent demands a significant focus to overrule the incidence of treatment failures. Adrenergic stimulation underlying the metastatic spread paved the way for beta blockers as a breakthrough in repurposing as an anti-metastatic agent. However, the current treatment approach fails to fully harness the versatile potential of the drug in inhibiting probable metastasis. The beta blockers were seen to show a myriad of grip over the pro-metastatic and prognostic parameters of the patient. Novel interventions in immune therapy, onco-hypertension, surgery-induced stress, induction of apoptosis and angiogenesis inhibition have been used as evidence to interpret our objective of discussing the potential adjuvant role of the drug in the existing anti-cancer regimens. Adding weight to the relative incidence of onco-hypertension as an unavoidable side effect from chemotherapy, the slot for an anti-hypertensive agent is necessitated, and we try to suggest beta-blockers to fill this position. However, pointing out the paucity in the clinical study, we aim to review the current status of beta blockers under this interest to state how the drug should be included as a drug of choice in every patient undergoing cancer treatment.

References

Spano D, Heck C, De Antonellis P, Christofori G, Zollo M . Molecular networks that regulate cancer metastasis. Semin Cancer Biol. 2012; 22(3):234-49. DOI: 10.1016/j.semcancer.2012.03.006. View

Bakhoum S, Cantley L . The Multifaceted Role of Chromosomal Instability in Cancer and Its Microenvironment. Cell. 2018; 174(6):1347-1360. PMC: 6136429. DOI: 10.1016/j.cell.2018.08.027. View

Essa H, Dobson R, Wright D, Lip G . Hypertension management in cardio-oncology. J Hum Hypertens. 2020; 34(10):673-681. PMC: 7398285. DOI: 10.1038/s41371-020-0391-8. View

Parker A, Benguigui M, Fornetti J, Goddard E, Lucotti S, Insua-Rodriguez J . Current challenges in metastasis research and future innovation for clinical translation. Clin Exp Metastasis. 2022; 39(2):263-277. PMC: 8971179. DOI: 10.1007/s10585-021-10144-5. View

Zhou Z, Shu Y, Bao H, Han S, Liu Z, Zhao N . Stress-induced epinephrine promotes epithelial-to-mesenchymal transition and stemness of CRC through the CEBPB/TRIM2/P53 axis. J Transl Med. 2022; 20(1):262. PMC: 9172202. DOI: 10.1186/s12967-022-03467-8. View

Xu J, Liao K, Yang X, Wu C, Wu W . Correction to: Using single-cell sequencing technology to detect circulating tumor cells in solid tumors. Mol Cancer. 2022; 21(1):100. PMC: 9014560. DOI: 10.1186/s12943-022-01564-2. View

Digernes I, Grovik E, Nilsen L, Saxhaug C, Geier O, Reitan E . Brain metastases with poor vascular function are susceptible to pseudoprogression after stereotactic radiation surgery. Adv Radiat Oncol. 2018; 3(4):559-567. PMC: 6200880. DOI: 10.1016/j.adro.2018.05.005. View

Follain G, Herrmann D, Harlepp S, Hyenne V, Osmani N, Warren S . Fluids and their mechanics in tumour transit: shaping metastasis. Nat Rev Cancer. 2019; 20(2):107-124. DOI: 10.1038/s41568-019-0221-x. View

Clement-Demange L, Mulcrone P, Tabarestani T, Sterling J, Elefteriou F . β2ARs stimulation in osteoblasts promotes breast cancer cell adhesion to bone marrow endothelial cells in an IL-1β and selectin-dependent manner. J Bone Oncol. 2018; 13:1-10. PMC: 6146568. DOI: 10.1016/j.jbo.2018.09.002. View

10.

Lou F, Huang J, Sima C, Dycoco J, Rusch V, Bach P . Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance. J Thorac Cardiovasc Surg. 2012; 145(1):75-81. DOI: 10.1016/j.jtcvs.2012.09.030. View

11.

Ushijima T, Sasako M . Focus on gastric cancer. Cancer Cell. 2004; 5(2):121-5. DOI: 10.1016/s1535-6108(04)00033-9. View

12.

Fischer R, Breidert M, Keck T, Makowiec F, Lohrmann C, Harder J . Early recurrence of pancreatic cancer after resection and during adjuvant chemotherapy. Saudi J Gastroenterol. 2012; 18(2):118-21. PMC: 3326972. DOI: 10.4103/1319-3767.93815. View

13.

Geisler J, Geisler H . Brain metastases in epithelial ovarian carcinoma. Gynecol Oncol. 1995; 57(2):246-9. DOI: 10.1006/gyno.1995.1134. View

14.

Amit M, Takahashi H, Dragomir M, Lindemann A, Gleber-Netto F, Pickering C . Loss of p53 drives neuron reprogramming in head and neck cancer. Nature. 2020; 578(7795):449-454. PMC: 9723538. DOI: 10.1038/s41586-020-1996-3. View

15.

Garona J, Alonso D . Perioperative biology in primary breast cancer: selective targeting of vasopressin type 2 receptor using desmopressin as a novel therapeutic approach. Breast Cancer Res Treat. 2016; 158(3):597-9. DOI: 10.1007/s10549-016-3899-4. View

16.

Kwak S, Kim S, Kim J, Kang Y, Ko C, Kim I . Tumor regionalization after surgery: Roles of the tumor microenvironment and neutrophil extracellular traps. Exp Mol Med. 2022; 54(6):720-729. PMC: 9256747. DOI: 10.1038/s12276-022-00784-2. View

17.

Sivanesan S, Tasken K, Grytli H . Association of β-Blocker Use at Time of Radical Prostatectomy With Rate of Treatment for Prostate Cancer Recurrence. JAMA Netw Open. 2022; 5(1):e2145230. PMC: 8792886. DOI: 10.1001/jamanetworkopen.2021.45230. View

18.

Sakamoto A, Yagi K, Okamura T, Harada T, Usuda J . Perioperative Administration of an Intravenous Beta-Blocker Landiolol Hydrochloride in Patients with Lung Cancer: A Japanese Retrospective Exploratory Clinical Study. Sci Rep. 2019; 9(1):5217. PMC: 6435747. DOI: 10.1038/s41598-019-41520-7. View

19.

Kooijmans E, van der Pal H, Pluijm S, Bresters D, van Dulmen-den Broeder E, van der Heiden-van der Loo M . Hypertension in long-term childhood cancer survivors after treatment with potentially nephrotoxic therapy; DCCSS-LATER 2: Renal study. Eur J Cancer. 2022; 172:287-299. DOI: 10.1016/j.ejca.2022.05.038. View

20.

Lipshultz S, Franco V, Miller T, Colan S, Sallan S . Cardiovascular disease in adult survivors of childhood cancer. Annu Rev Med. 2015; 66:161-76. PMC: 5057395. DOI: 10.1146/annurev-med-070213-054849. View